Colourless Copaxone in the clear: Teva's synthesis patents held to be (mostly) valid By Darren Smyth on Thursday, May 21, 2015 copaxone expert evidence glatiramer acetate insufficiency inventive step novelty patent purity squeeze Synthon Teva validity +